A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation

Romel Somwar, Sandra Koterski, Gary Sweeney, Richard Sciotti, Stevan Djuric, Cathy Berg, James Trevillyan, Philipp E. Scherer, Christina M. Rondinone, Amira Klip

Research output: Contribution to journalArticlepeer-review

109 Scopus citations

Fingerprint

Dive into the research topics of 'A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds